ADORA2A and metabolic syndrome: Adenosine and adenosine receptors play a role in modulating cholesterol content in macrophages by enhancing cholesterol efflux through A2AR activation and suppressing inflammation through A2AR and A2BR activation, which are implicated in the development of atherosclerosis and dyslipidemia [93].